Literature DB >> 10848733

Mast cell mediators other than histamine induce pruritus in atopic dermatitis patients: a dermal microdialysis study.

R Rukwied1, G Lischetzki, F McGlone, G Heyer, M Schmelz.   

Abstract

While histamine is the crucial mediator of pruritus in type 1 allergic reactions, its role in atopic dermatitis (AD) is unclear. In this study, the role of mast cell mediators in protein extravasation and pruritus was evaluated using intradermal microdialysis. The microdialysis capillaries were used to apply the mast cell degranulating substance compound 48/80 (C48/80; 0.05%) or histamine (0.01%) and also to deliver H1-blockers (cetirizine, 200 microg mL-1) in nine AD patients and nine controls. Large pore size membranes (3000 kDa) enabled simultaneous analysis of protein extravasation. Itch sensation was measured psychophysically and weal and flare reaction were evaluated planimetrically. Protein extravasation induced by histamine and C48/80 was significantly reduced in AD patients. Blockade of H1-receptors by cetirizine significantly reduced C48/80-induced protein extravasation in AD patients and controls to an identical level. C48/80-induced pruritus was abolished by cetirizine in controls, whereas pruritus in AD patients was unchanged after H1 blockade. We conclude that mast cell mediators others than histamine are involved in C48/80-induced pruritus in AD patients. Whether the reduced capacity of AD patients to induce protein extravasation is of pathophysiological relevance for pruritus remains to be established.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10848733     DOI: 10.1046/j.1365-2133.2000.03535.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  26 in total

1.  Pruritus: an updated look at an old problem.

Authors:  Yvette A Tivoli; Richard M Rubenstein
Journal:  J Clin Aesthet Dermatol       Date:  2009-07

2.  Macelignan inhibits histamine release and inflammatory mediator production in activated rat basophilic leukemia mast cells.

Authors:  Young Sun Han; Myung-Suk Kim; Jae-Kwan Hwang
Journal:  Inflammation       Date:  2012-10       Impact factor: 4.092

3.  Pruritus in the elderly: clinical approaches to the improvement of quality of life.

Authors:  Kenneth R Cohen; Jerry Frank; Rebecca L Salbu; Igor Israel
Journal:  P T       Date:  2012-04

Review 4.  Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?

Authors:  Nicholas K Mollanazar; Peter K Smith; Gil Yosipovitch
Journal:  Clin Rev Allergy Immunol       Date:  2016-12       Impact factor: 8.667

Review 5.  Atopic dermatitis in children: clinical features, pathophysiology, and treatment.

Authors:  Jonathan J Lyons; Joshua D Milner; Kelly D Stone
Journal:  Immunol Allergy Clin North Am       Date:  2014-11-21       Impact factor: 3.479

Review 6.  Oral H1 antihistamines as monotherapy for eczema.

Authors:  Christian J Apfelbacher; Esther J van Zuuren; Zbys Fedorowicz; Aldrin Jupiter; Uwe Matterne; Elke Weisshaar
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

7.  PAR2 Pepducin-Based Suppression of Inflammation and Itch in Atopic Dermatitis Models.

Authors:  Travis P Barr; Chris Garzia; Srijoy Guha; Elizabeth K Fletcher; Nga Nguyen; Adam J Wieschhaus; Lluis Ferrer; Lidija Covic; Athan Kuliopulos
Journal:  J Invest Dermatol       Date:  2018-10-01       Impact factor: 8.551

8.  Bee venom ameliorates compound 48/80-induced atopic dermatitis-related symptoms.

Authors:  Kyung-Hyun Kim; Woo-Ram Lee; Hyun-Jin An; Jung-Yeon Kim; Hyun Chung; Sang-Mi Han; Myeong-Lyoel Lee; Kwang-Gill Lee; Sok Cheon Pak; Kwan-Kyu Park
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

9.  Mast cell degranulation activates a pain pathway underlying migraine headache.

Authors:  Dan Levy; Rami Burstein; Vanessa Kainz; Moshe Jakubowski; Andrew M Strassman
Journal:  Pain       Date:  2007-04-24       Impact factor: 6.961

10.  Barely scratching the surface.

Authors:  Aaron I Vinik
Journal:  Diabetes Care       Date:  2010-01       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.